Published in Mol Pharmacol on March 01, 1974
Correlation of double-minute chromosomes with unstable multidrug cross-resistance in uptake mutants of neuroblastoma cells. Proc Natl Acad Sci U S A (1981) 1.28
The biochemical events of mitosis. I. Synthesis and properties of colchicine labeled with tritium in its acetyl moiety. Biochemistry (1966) 2.74
The biochemical events of mitosis. II. The in vivo and in vitro binding of colchicine in grasshopper embryos and its possible relation to inhibition of mitosis. Biochemistry (1967) 2.62
Alzheimer's disease and its Lewy body variant: a clinical analysis of postmortem verified cases. Am J Psychiatry (1996) 2.30
Vasoactive intestinal polypeptide: abundant immunoreactivity in neural cell lines and normal nervous tissue. Science (1976) 1.76
DNA-triplet repeats and neurologic disease. N Engl J Med (1996) 1.60
Competent patients with advanced states of permanent paralysis have the right to forgo life-sustaining therapy. Neurology (1993) 1.58
Familial opticoacoustic nerve degeneration and polyneuropathy. Neurology (1967) 1.50
Category fluency in mild cognitive impairment: reduced effect of practice in test-retest conditions. Alzheimer Dis Assoc Disord (2004) 1.48
Antimalarial activity of tetrahydrohomopteroic acid. Science (1967) 1.44
Peripheral neuropathy and starvation after gastric partitioning for morbid obesity. Ann Intern Med (1982) 1.31
Thymidylate synthetase. Adv Enzymol Relat Areas Mol Biol (1973) 1.30
Correlation of double-minute chromosomes with unstable multidrug cross-resistance in uptake mutants of neuroblastoma cells. Proc Natl Acad Sci U S A (1981) 1.28
Autosomal dominant striatonigral degeneration. A clinical, pathologic, and biochemical study of a new genetic disorder. Neurology (1976) 1.27
Markers for gene expression in cultured cells from the nervous system. J Biol Chem (1972) 1.26
Antitubulin agents enhance the stimulation of DNA synthesis by polypeptide growth factors in 3T3 mouse fibroblasts. Proc Natl Acad Sci U S A (1979) 1.23
Transverse myelitis associated with heroin addiction. JAMA (1968) 1.22
Autosomal dominant cerebellar phenotypes: the genotype has settled the issue. Neurology (1995) 1.21
Effects of practice on category fluency in Alzheimer's disease. Clin Neuropsychol (2001) 1.20
Regulation of choline kinase activity and phosphatidylcholine biosynthesis by mitogenic growth factors in 3T3 fibroblasts. J Biol Chem (1985) 1.19
Apoptosis and neurologic disease. Am J Med (2000) 1.17
Mid-G1 marker protein(s) in 3T3 mouse fibroblast cells. Proc Natl Acad Sci U S A (1978) 1.14
Mononeuritis multiplex in lepromatous leprosy. Arch Neurol (1968) 1.12
Neurologic involvement in Urbach-Wiethe's disease (lipoid proteinosis). A clinical, ultrastructural, and chemical study. Neurology (1971) 1.07
Platelet APP isoform ratios correlate with declining cognition in AD. Neurology (2000) 1.01
Olivopontocerebellar degeneration. Clinical and ultrastructural abnormalities. Arch Neurol (1974) 1.01
Comparison of the hopkins verbal learning test-revised to the California verbal learning test in Alzheimer's disease. Appl Neuropsychol (2001) 1.00
Neurological complications of fibrous dysplasia of the skull. Arch Neurol (1968) 0.99
Colchicine inhibits epidermal growth factor degradation in 3T3 cells. Proc Natl Acad Sci U S A (1980) 0.99
Joseph's disease: an autosomal dominant neurological disease in the Portuguese of the United States and the Azores Islands. Adv Neurol (1978) 0.97
The natural history of Machado-Joseph disease. An analysis of 138 personally examined cases. Can J Neurol Sci (1984) 0.97
Creatine kinase BB isoenzyme levels by radioimmunoassay in patients with neurological disease. Ann Neurol (1978) 0.97
Regulation of phosphatidylcholine biosynthesis by mitogenic growth factors. Biochim Biophys Acta (1984) 0.95
Inhibition of thymidylate synthetase and dihydrofolate reductase by naturally occurring oligoglutamate derivatives of folic acid. J Biol Chem (1975) 0.95
Detection of DNA synthesis in intact organisms with positron-emitting (methyl- 11 C)thymidine. Proc Natl Acad Sci U S A (1972) 0.95
Glial tumor metastases through a ventriculo-pleural shunt. Resultant massive pleural effusion. Arch Neurol (1968) 0.94
The Machado-Joseph disease locus is different from the spinocerebellar ataxia locus (SCA1). Genomics (1992) 0.94
Vasoactive intestinal polypeptide in brain synaptosomes. Lancet (1976) 0.91
Apolipoprotein E epsilon 4, other risk factors, and course of Alzheimer's disease. Biol Psychiatry (1999) 0.91
Joseph disease: an autosomal dominant motor system degeneration. Adv Neurol (1984) 0.90
Progressive ophthalmoplegia. Report of cases. Arch Neurol (1968) 0.90
Prion proteins: a biological role beyond prion diseases. Acta Neurol Scand (2007) 0.90
Differences in the distribution of poly(A) size classes in individual messenger RNAs from neuroblastoma cells. J Biol Chem (1979) 0.89
Physiology of glia: glial-neuronal interactions. Int Rev Neurobiol (1979) 0.88
Frontal lobe ataxia. Surg Neurol (1995) 0.87
Reversible inactivation and reactivation of thymidylate synthetase. Adv Enzyme Regul (1972) 0.86
Thymidylate synthetase in mouse erythrocytes infected with Plasmodium berghei. Mol Pharmacol (1973) 0.86
The hydrolysis of mono-, di-, and triglutamate derivatives of folic acid with bacterial enzymes. J Biol Chem (1968) 0.86
Experimental chemotherapy of neuroblastoma. II. Increased thymidylate synthetase activity in a 5-fluorodeoxyuridine-resistant variant of mouse neuroblastoma. Mol Pharmacol (1975) 0.86
Correlation of statin-increased platelet APP ratios and reduced blood lipids in AD patients. Neurology (2003) 0.85
A radioisotopic, chromatographic microassay for acetyl-coenzyme A synthetase and some preliminary studies on the rat brain enzyme. Biochim Biophys Acta (1973) 0.85
Induction of adenosine 3',5'-monophosphate binding proteins by N6,O2'-dibutyryladenosine 3',5'-monophosphate in mouse neuroblastoma cells. Analysis by two-dimensional gel electrophoresis. Biochemistry (1979) 0.84
Autosomal dominant progressive syndrome of motor-speech loss without dementia. Neurology (1997) 0.84
Altered apolipoprotein E secretion in cytokine treated human astrocyte cultures. J Neurol Sci (1997) 0.84
Serum antibodies to cytomegalovirus in myasthenia gravis: effects of thymectomy and steroids. Neurology (1978) 0.83
Genetic and immunological studies of bacteriophage T4 thymidylate synthetase. J Virol (1973) 0.83
Glutamate and malate dehydrogenase activities in Joseph disease and olivopontocerebellar atrophy. Neurology (1987) 0.83
The role of cytoplasmic microtubules in the regulation of the activity of peptide growth factors. Adv Enzyme Regul (1980) 0.82
Studies with tetrahydrohomofolate and thymidylate synthetase from amethopterin-resistant mouse leukemia cells. Biochemistry (1968) 0.82
Regulation of the synthesis of choline-O-acetyltransferase and thymidylate synthetase in mouse neuroblastoma in cell culture. Proc Natl Acad Sci U S A (1971) 0.82
Specific messenger RNA changes in Joseph disease cerebella. Ann Neurol (1983) 0.82
Machado Joseph disease maps to the same region of chromosome 14 as the spinocerebellar ataxia type 3 locus. J Med Genet (1995) 0.82
Altered thymidine kinase or thymidylate synthetase activities in 5-fluoro deoxyuridine resistant variants of mouse neuroblastoma. J Neurochem (1977) 0.81
Reye's syndrome: isolation of parainfluenza virus. Report of three cases. Arch Neurol (1973) 0.81
Quantitation and characterisation of poly(A)-containing messenger RNAs from mouse neuroblastoma cells. Biochim Biophys Acta (1977) 0.81
Furosemide-sensitive K+ channel in glioma cells but not neuroblastoma cells in culture. Biochem Biophys Res Commun (1982) 0.81
Idiopathic polyneuropathy associated with cytotoxic anti-neuroblastoma serum. IgG and IgM immunoglobulin studies. Neurology (1975) 0.81
Hypothermia and persisting capacity to develop fever. Occurrence in a patient with sarcoidosis of the central nervous system. Arch Neurol (1977) 0.81
Enhancement of DNA synthesis by colchicine in 3T3 mouse fibroblasts stimulated with growth factors. Exp Cell Res (1980) 0.81
A comparison of thymidylate synthetase activities from 5-fluorodeoxyuridine sensitive and resistant variants of mouse neuroblastoma. J Neurochem (1975) 0.81
Joseph disease and Huntington disease: protein patterns in fibroblasts and brain. Neurology (1981) 0.80
Induction of cyclic AMP-binding proteins by dibutyryl cyclic AMP in mouse neuroblastoma cells. Biochim Biophys Acta (1978) 0.80
An AP-2 binding sequence within exon 1 of human and porcine choline acetyltransferase genes enhances transcription in neural cells. Neuroscience (1997) 0.80
Xenon-133 SPECT-determined regional cerebral blood flow in Alzheimer's disease: what is typical? J Neuropsychiatry Clin Neurosci (1993) 0.79
alpha-L-iduronidase deficiency and possible Hurler-Scheie genetic compound. Clinical, pathologic, and biochemical findings. Neurology (1976) 0.79
The biochemist's outlook on cancer research. Fed Proc (1973) 0.79
Sleep apnea and hypoventilation syndrome associated with acquired nonprogressive dysautonomia: clinical and pathological studies in a child. Ann Neurol (1981) 0.79
Molecular genetics, recombinant DNA techniques, and genetic neurological disease. Ann Neurol (1984) 0.79
Recombinant DNA and neurologic disease: the coming of a new age. Neurology (1983) 0.78
Comparison of the CERAD and CVLT list-learning tasks in Alzheimer's disease. Clin Neuropsychol (2000) 0.78
Empirical vs. rational approaches in cancer chemotherapy. Ann N Y Acad Sci (1971) 0.78
Decreased 6-mercaptopurine retention by two resistant variants of mouse neuroblastoma with normal hypoxanthine-guanine-phospho-ribosyltransferase activities. J Pharmacol Exp Ther (1975) 0.78
Amplification signals anticipation--less DNA is better. Neurology (1992) 0.78
Effect of dopamine agonist (Lergotrile mesylate) therapy on twenty-four hour secretion of prolactin in treated Parkinson's disease. J Clin Endocrinol Metab (1978) 0.78
Molecular neurogenetics: the genome is settling the issue. JAMA (1997) 0.78
Plasmodium berghei: folic acid levels in mouse erythrocytes. Exp Parasitol (1973) 0.77
Machado Joseph disease is not an allele of the spinocerebellar ataxia 2 locus. Hum Genet (1994) 0.77
Urine vapor pattern for olivopontocerebellar degeneration. Clin Biochem (1975) 0.76
Increased release of an amyloidogenic C-terminal Alzheimer amyloid precursor protein fragment from stressed PC-12 cells. J Neurosci Res (1991) 0.76
Genomic neurology: a new beginning. Arch Neurol (2001) 0.76
Memory loss--when is it Alzheimer disease? JAMA (1998) 0.76
Morphological differentiation and proteoglycan synthesis regulate Alzheimer amyloid precursor protein processing in PC-12 and human astrocyte cultures. J Neurosci Res (1992) 0.76
Neurotherapeutics, evidence-based neurology, and clinical equipoise. Arch Neurol (1999) 0.76
Aging and Alzheimer's disease: lessons from the Nun Study. Gerontologist (1998) 0.76
Erroneous diagnosis corrected after 28 years. Not spinal muscular atrophy with ophthalmoplegia but minicore myopathy. Arch Neurol (1996) 0.76
18F-5-Fluorouridine, a new probe for measuring the proliferation of tissue in vivo. Adv Enzyme Regul (1982) 0.76
Acid-soluble precursors and derivatives of phospholipids increase after stimulation of quiescent Swiss 3T3 mouse fibroblasts with serum. Biochem Biophys Res Commun (1980) 0.76
Platelet APP isoform ratios in asymptomatic young adults expressing an AD-related presenilin-1 mutation. J Neurol Sci (2001) 0.76
The 1990s--decade of the brain: the need for a national priority. Neurology (1990) 0.76